HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systemic complement activation and acute lung injury.

Abstract
Experimental studies of rats have provided significant evidence that intravascular complement activation after i.v. injection of cobra venom factor (CVF) or thermal injury of skin can result in acute lung injury. This has been determined by morphological changes in lung and increases in lung vascular permeability. Systemic complement activation is associated with an early appearance of C5-derived chemotactic activity in the circulation coincident with the development of transient neutropenia, followed by extensive granulocytosis and sequestration of neutrophils in lung interstitial capillaries. The acute pulmonary injury depends on availability of complement and neutrophils. Depletion of either complement or blood neutrophils before CVF injection or thermal injury will prevent development of lung injury. Interventional studies with catalase, scavengers of hydroxyl radical OH., and iron chelators have revealed that the acute pulmonary injury is related to production of oxygen-derived free radicals by activated neutrophils. OH. appears to be the key mediator involved in the acute lung microvascular injury.
AuthorsG O Till, P A Ward
JournalFederation proceedings (Fed Proc) Vol. 45 Issue 1 Pg. 13-8 (Jan 1986) ISSN: 0014-9446 [Print] United States
PMID3940902 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Complement C5
  • Elapid Venoms
  • Free Radicals
  • Complement C5a
Topics
  • Acute Disease
  • Animals
  • Capillary Permeability (drug effects)
  • Complement Activation (drug effects)
  • Complement C5 (physiology)
  • Complement C5a
  • Elapid Venoms (pharmacology)
  • Endothelium (pathology)
  • Free Radicals
  • Hot Temperature
  • Inflammation (pathology, physiopathology)
  • Leukocyte Count
  • Lung (blood supply, pathology)
  • Neutrophils (metabolism, pathology)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: